Announced
Financials
Sources
Tags
Private
Acquisition
Majority
Cross Border
Private Equity
Pending
Friendly
medical technology
Single Bidder
Medical Equipment
Japan
Synopsis
The Carlyle Group, a global investment firm, agreed to invest $53m in CureApp, a Japanese medical technology company. "We see tremendous growth opportunities for digital therapeutics in helping to address the growing social needs of Japan’s ageing population, to advance public health access, and to reduce overall healthcare costs through early intervention. CureApp has a distinct competitive market advantage as a leading prescription digital therapeutics company. We are excited to partner with its co-founders for Carlyle Japan’s second strategic growth investment and to help advance digital health solutions in Japan," Kazuhiro Yamada, Carlyle Managing Director and Head of Japan.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.